Acta Neurologica Scandinavica · 2006 · 26 citations · 7 references
MedicineImmunologyNeurologyElectrodiagnostic MedicineElectrophysiologyNeuromuscular DisordersMuscle DisordersMuscle PathologyMuscle WeaknessMyasthenia GravisNeuromuscular ChangesNeuromuscular JunctionAnti-acetylcholine Receptor AntibodiesAnti-muscle-specific Kinase AntibodiesElectromyographyJitterMuscle-specific Kinase AntibodiesMusk Antibody-mediated DiseaseNeuromuscular Junction AntibodiesNeuromuscular Junction Transmission
The presence of antibodies against muscle-specific receptor tyrosine kinase (MuSK) appears to define a subgroup of patients with myasthenia gravis (MG) characterized by weakness predominant in bulbar, facial and neck muscles compared with anti-acetylcholine receptor (AChR) antibody-positive MG. To investigate the patterns and severity of neuromuscular transmission failure in different muscles in MuSK-positive MG, we performed single fiber electromyography (SFEMG) in the facial (frontalis) and limb (extensor digitorum communis, EDC) muscles in three anti-Musk-positive patients, and compared results with those of 11 anti-AChR-positive patients. Only one of the three MuSK-positive patients had abnormal jitter in EDC, but all the three showed clearly increased jitter in the frontalis. By contrast, the AChR-positive patients showed similarly abnormal jitter for the two muscles. These results suggest that when the diagnosis of anti-MuSK-positive MG is suspected, SFEMG should be performed in most prominently affected muscles.
7
Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis
Amelia Evoli · Brain · 2003 · 613 citations
Medicine, Immunology, Pathology +15
Clinical aspects of MuSK antibody positive seronegative MG
Donald B. Sanders, Khalid El‐Salem, Janice M. Massey et al. · Neurology · 2003 · 409 citations
Medicine, Immunology, Neurology +17